Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
HireQuest
HQI
$239M
| $91.7K | ﹤0.01% |
8,721
+886
| +11% | +$7.81K |
|
4527
Innovator US Equity Power Buffer ETF April
PAPR
$959M
| $91.6K | ﹤0.01% |
+2,341
| New | +$90.5K |
|
4528
Quantum Corp
QMCO
$765M
| $91.6K | ﹤0.01% |
14,197
+13,742
| +3,020% | +$123K |
|
|
ACTU
4529
Actuate Therapeutics
ACTU
$24.2M
| $91.5K | ﹤0.01% |
14,946
+6,081
| +69% | +$41.8K |
|
4530
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.47B
| $91.1K | ﹤0.01% |
+2,000
| New | +$92.4K |
|
4531
Surf Air Mobility
SRFM
$98.9M
| $89.7K | ﹤0.01% |
46,233
+31,278
| +209% | +$100K |
|
4532
Invesco DB Energy Fund
DBE
$91.6M
| $89.2K | ﹤0.01% |
+5,105
| New | +$95.3K |
|
4533
Century Casinos
CNTY
$34.3M
| $88.9K | ﹤0.01% |
66,852
-86
| -0.1% | -$154 |
|
4534
Global X Autonomous & Electric Vehicles ETF
DRIV
$392M
| $88.8K | ﹤0.01% |
3,000
| – | – |
|
|
PAMT
4535
PAMT Corp
PAMT
$281M
| $88.6K | ﹤0.01% |
7,337
-1,160
| -14% | -$12.3K |
|
4536
inTEST
INTT
$171M
| $88.5K | ﹤0.01% |
11,846
-19
| -0.2% | -$150 |
|
|
ELVR
4537
Elevra Lithium Ltd
ELVR
$1.16B
| $86.8K | ﹤0.01% |
1,652
-7
| -0.4% | -$240 |
|
4538
Rhinebeck Bancorp
RBKB
$195M
| $86.7K | ﹤0.01% |
7,210
+778
| +12% | +$8.54K |
|
|
FHDG
4539
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$70.5M
| $86.4K | ﹤0.01% |
2,546
+1,036
| +69% | +$34.6K |
|
4540
Defiance Quantum ETF
QTUM
$5.63B
| $86K | ﹤0.01% |
+784
| New | +$86.4K |
|
|
TEAD
4541
Teads Holding Co
TEAD
$65.6M
| $85.5K | ﹤0.01% |
121,426
+6,006
| +5% | +$6.36K |
|
4542
Camtek
CAMT
$7.67B
| $85.3K | ﹤0.01% |
802
-4,397
| -85% | -$494K |
|
4543
Neuronetics
STIM
$222M
| $85K | ﹤0.01% |
61,606
+9,941
| +19% | +$20.8K |
|
4544
PUT
Lamb Weston
LW
$7.23B
| $83.8K | ﹤0.01% |
2,000
-523,000
| -100% | -$30.8M |
|
4545
CALL
Charter Communications
CHTR
$18.8B
| $83.5K | ﹤0.01% |
400
| – | – |
|
4546
Banco Santander Chile
BSAC
$16.5B
| $82.9K | ﹤0.01% |
2,666
+2,334
| +703% | +$68K |
|
|
SWKH
4547
DELISTED
SWK Holdings
SWKH
| $82.5K | ﹤0.01% |
4,794
+489
| +11% | +$8.07K |
|
4548
Ispire Technology
ISPR
$99.9M
| $82.4K | ﹤0.01% |
29,433
+2,419
| +9% | +$5.62K |
|
|
NXXT
4549
NextNRG Inc
NXXT
$47M
| $81.8K | ﹤0.01% |
56,411
+29,357
| +109% | +$50.6K |
|
|
TBN
4550
Tamboran Resources
TBN
$1.26B
| $81.4K | ﹤0.01% |
2,990
-956
| -24% | -$24.3K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.